WO2015099108A1 - Sachet de volatilisation chimique et contenant de volatilisation chimique le contenant - Google Patents

Sachet de volatilisation chimique et contenant de volatilisation chimique le contenant Download PDF

Info

Publication number
WO2015099108A1
WO2015099108A1 PCT/JP2014/084474 JP2014084474W WO2015099108A1 WO 2015099108 A1 WO2015099108 A1 WO 2015099108A1 JP 2014084474 W JP2014084474 W JP 2014084474W WO 2015099108 A1 WO2015099108 A1 WO 2015099108A1
Authority
WO
WIPO (PCT)
Prior art keywords
bag
volatilization
chemical
volatile
bag body
Prior art date
Application number
PCT/JP2014/084474
Other languages
English (en)
Japanese (ja)
Inventor
祐子 中村
勇人 井實
Original Assignee
小林製薬株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 小林製薬株式会社 filed Critical 小林製薬株式会社
Publication of WO2015099108A1 publication Critical patent/WO2015099108A1/fr

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/26—Accessories or devices or components used for biocidal treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2202/00—Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
    • A61L2202/10—Apparatus features
    • A61L2202/18—Aseptic storing means
    • A61L2202/181—Flexible packaging means, e.g. permeable membranes, paper

Definitions

  • the present invention relates to a drug volatilization bag in which a volatile drug such as a fragrance or a deodorant is encapsulated, and a drug volatilization container for storing the drug volatilization bag.
  • the fragrance package disclosed in this Patent Document 1 has a heat seal property on the inner surface and is made of a multilayer film including a gas barrier film layer, and the open end portion easily presses the bag containing the contents easily.
  • a volatile fragrance is filled and sealed in an inner packaging bag that is sealed to such an extent that it can be peeled easily, and the inner packaging bag that is filled and sealed with the fragrance is made of a gas permeable film. It is sealed and packaged with a packaging bag (see FIG. 2 of Patent Document 1).
  • the inner packaging bag When using this fragrance package, the inner packaging bag is pressed from the outside through the outer packaging bag, and the inner pressure of the inner packaging bag is increased by the external force. The fragrance flows out into the packaging bag. Since this outer packaging bag is made of a gas permeable film, the fragrance that has flowed into the outer packaging bag is volatilized to the outside through the gas permeable film.
  • both surfaces of the outer packaging bag are constituted by gas permeable films.
  • gas permeable films such as polyethylene have poor permeability to alcohols such as linalool and dihydromyrsenol, which are the main components of the fragrance constituting the fragrance, and may limit volatilization. .
  • flavor has a various component, and its chemical property is also various.
  • the gas permeability of the gas permeable film constituting the outer packaging bag varies depending on the material. Therefore, the familiarity between the fragrance and the gas permeable film is good, and a combination of the fragrance and the gas permeable film that can vaporize the fragrance from the outer packaging bag must be selected. As a result, there is a problem that usable fragrances are restricted with respect to the gas permeable film constituting the outer packaging bag.
  • the present invention has been proposed in view of the above-described problems, and the object of the present invention is to improve the degree of freedom of selection when using volatile agents such as fragrances and deodorants. It is in providing a chemical volatilization bag and a chemical volatilization container which stores this.
  • a drug volatilization bag according to the present invention is formed of a gas non-permeable film, a soft inner bag body in which a volatile drug is enclosed, and the inner bag.
  • the microporous sheet constituting at least one surface of the outer bag body is different from a gas permeable film that allows a gas of a volatile drug to permeate at a molecular level, so that the volatile drug infiltrates and oozes on the sheet surface.
  • a gas permeable film that allows a gas of a volatile drug to permeate at a molecular level, so that the volatile drug infiltrates and oozes on the sheet surface.
  • the other surface of the outer bag body can be formed of, for example, a sheet that cannot be infiltrated with a volatile drug, in addition to the above-described microporous sheet.
  • a gas permeable film that allows the gas of the volatile drug to permeate at a molecular level or a gas impermeable film that blocks the gas of the volatile drug can be applied.
  • the material of the sheet constituting the other surface of the outer bag body is arbitrary.
  • the volatile drug sealed in the inner bag flows out into the outer bag.
  • the outer bag body is composed of a microporous sheet having at least one surface that has a large number of micropores into which the volatile drug can infiltrate, the volatile drug that has flowed into the outer bag body is a microporous sheet. Volatilizes to the outside by infiltrating through the micropores and exuding on the sheet surface.
  • the microporous sheet constituting at least one surface of the outer bag body is one in which a large number of micropores are physically formed to such an extent that the volatile drug infiltrates and exudes to the sheet surface, Unlike conventional gas permeable films, there is no need to select a combination of volatile chemicals with a wide variety of chemical properties, there are a wide variety of volatile chemicals that can be used, and volatile chemicals can be easily removed from the outer bag. Can be stripped. In this way, the volatile chemicals that can be used are not restricted with respect to the microporous sheet constituting at least one surface of the outer bag, so that the degree of freedom in selecting the volatile chemicals can be increased. Can be improved.
  • the volatile agent infiltrates with a large number of micropores and oozes out on the surface of the sheet. Therefore, the volatilization amount of the volatile agent is larger than that of the gas permeable film. Can be volatilized well from the outer bag. Therefore, it is not always necessary to configure both sides of the outer bag body with the microporous sheet, and it is sufficient that at least one surface of the outer bag body is configured with the microporous sheet.
  • the drug volatilization container according to the present invention is a case in which the above-mentioned drug volatilization bag is accommodated and a pressing portion for applying an external force to the inner bag body via the outer bag body is provided at a site corresponding to the inner bag body. It is comprised by these.
  • this chemical volatilization container it is desirable to attach the case to the member to be attached in a state where the chemical volatilization bag is arranged with one surface of the outer bag body made of a microporous sheet facing upward.
  • an external force is applied to the inner bag body via the outer bag body of the chemical volatilization bag by pushing the pressing part of the case against the chemical volatilization bag stored in the case. To do.
  • the internal pressure of the inner bag increases, and the inner bag breaks with the increase of the internal pressure. Due to the inner bag body breaking, the volatile drug sealed in the inner bag body flows out into the outer bag body.
  • the volatile chemicals that have flowed into the outer bag body infiltrate through the micropores of the microporous sheet and ooze out to the surface of the sheet to evaporate to the outside.
  • this chemical volatilization container As a usage form of this chemical volatilization container, it is possible to arrange the chemical volatilization bag in the case in a vertically placed state and to arrange the chemical volatilization bag in the case in a laterally placed state.
  • the chemical volatilization bag is directed with the one side of the outer bag body composed of the microporous sheet facing upward. If it arrange
  • At least one surface of the outer bag is composed of a microporous sheet having a large number of micropores that can be infiltrated with a volatile drug.
  • a microporous sheet having a large number of micropores that can be infiltrated with a volatile drug.
  • volatile chemicals that have a wide variety of chemical properties, and there are many types of volatile chemicals that can be used. Can do.
  • the volatile chemicals that can be used are not restricted with respect to the microporous sheet constituting at least one surface of the outer bag, so that the degree of freedom in selecting the volatile chemicals can be increased. Can be improved.
  • FIG. 2 is an assembled perspective view showing the chemical volatilization bag of FIG. 1.
  • FIG. 3 is a cross-sectional view taken along line AA in FIG. 2. It is sectional drawing which shows the use condition of the chemical volatilization bag of FIG. The case which accommodates a chemical volatilization bag is shown, (A) is a top view, (B) is a front view, (C) is a bottom view.
  • FIG. 6 is a cross-sectional view taken along the line BB in FIG. It is a bottom view which shows one case half.
  • FIG. 8 is a cross-sectional view taken along the line CC of FIG.
  • FIG. 10 is a cross-sectional view taken along the line DD in FIG. 9. It is an assembly exploded perspective view showing a medicine volatilization container consisting of a case and a medicine volatilization bag. It is an assembly disassembled perspective view which shows the state which mounted the chemical volatilization bag in the case. It is an assembly completion perspective view which shows the chemical volatilization container which consists of a case and a chemical volatilization bag. It is sectional drawing which shows the use condition which equipped the lid
  • Embodiments of a drug volatilization bag and a drug volatilization container for storing the drug volatilization bag according to the present invention will be described in detail below.
  • a trash box fragrance a case where it is attached to the inside of a trash box lid is illustrated, but in addition to a trash box fragrance, it can also be applied as a fragrance or deodorant in a room or a car interior. .
  • FIG. 1 is an exploded perspective view
  • FIG. 2 is a perspective view of completion of assembly
  • FIG. 3 is a cross-sectional view taken along the line AA in FIG. FIG.
  • the chemical volatilization bag 11 has a double structure including a soft inner bag body 12 and a soft outer bag body 13 that accommodates the inner bag body 12. . 3 and 4, the thickness and the internal space of the inner bag body 12 and the outer bag body 13 are exaggerated.
  • the inner bag body 12 having a rectangular shape in plan view is formed into a bag shape with a transparent gas-impermeable film 14, and a volatile drug 15 is enclosed therein.
  • the gas non-permeable film 14 that is the material of the inner bag 12 include thermoplastic synthetic resins such as polyester, polyamide, saponified ethylene-vinyl acetate copolymer, modified polyvinyl alcohol, and polyvinylidene chloride, and aluminum.
  • thermoplastic synthetic resins such as polyester, polyamide, saponified ethylene-vinyl acetate copolymer, modified polyvinyl alcohol, and polyvinylidene chloride, and aluminum.
  • medical agent 15 paraffin type hydrocarbons, glycol ethers, glycols, alcohols, ester, ketones, lactones, aldehydes etc.
  • the volatile drug can be used as a chemical
  • the volatile drug is not limited to a liquid, and may be a solid, gel, sol, or a mixture thereof. If this volatile chemical
  • the inner bag body 12 is formed into a bag shape by folding a single gas-impermeable film 14 in two and heat-sealing the three side portions 16 that are opened by heat sealing.
  • the three side portions 16 are sealed with such a strength that can be broken by an increase in internal pressure due to an external force. In that case, the number and location of the side portions 16 to be sealed so as to be broken are arbitrary.
  • one gas impermeable film 14 is folded in two and the three side portions 16 are sealed so as to be able to break the bag, but the two gas impermeable films 14 are overlapped. It is also possible to form a bag by combining them, and in that case, the number and location of the side portions 16 to be sealed so as to be broken are arbitrary.
  • the outer bag 13 having a rectangular shape in plan view overlaps one microporous sheet 17 that constitutes one surface and one transparent sheet 18 that constitutes the other surface opposite thereto, and opens.
  • the four side portions 19 are heat-sealed by heat sealing to form a bag shape.
  • the microporous sheet 17 may constitute a part of one surface other than the entire surface of the outer bag 13.
  • the four side portions 19 of the outer bag body 13 are sealed so as not to break the bag due to an increase in internal pressure due to an external force.
  • seat which comprises the other surface of this outer bag 13 does not necessarily need to be transparent, and is non-transparent. Alternatively, it may be translucent or a microporous sheet.
  • the microporous sheet 17 constituting one surface of the outer bag 13 has a large number of micropores into which the volatile drug 15 can be infiltrated. That is, unlike the gas permeable film that allows the gas of the volatile drug 15 to pass therethrough, a large number of micropores are physically formed to such an extent that the volatile drug 15 infiltrates and oozes out on the sheet surface.
  • microporous sheet 17 examples include various polyethylenes such as high-density polyethylene, medium-density polyethylene, low-density polyethylene, linear low-density polyethylene, and ultra-high molecular weight polyethylene, ethylene-vinyl acetate copolymer, and ken , Ethylene-acrylic copolymers, ethylene-propylene copolymers, various olefin resins and their copolymers, diene resins and their copolymers, polyethylene terephthalate, polybutylene terephthalate, polycarbonate, polystyrene, polychlorinated Examples include vinyl, polyvinylidene chloride, polycarbonate, polyurethane, various acrylic resins, polyvinyl alcohol, polyimide, fluorine resin, silicon resin, epoxy resin, and semisynthetic resin such as cellophane.
  • polyethylenes such as high-density polyethylene, medium-density polyethylene, low-density polyethylene,
  • the resin used for the microporous sheet 17 may be used alone or as a copolymer or a blend. Furthermore, it is good also as a multilayer sheet which made the above-mentioned resin into multiple layers. In order to obtain a multilayer sheet, it is carried out by known means such as dry lamination, co-extrusion, and extrusion lamination. In molding into a sheet, various additives may be kneaded, or stretching or heat treatment may be performed after molding. You may perform coating, vapor deposition, etc. after shaping
  • the transparent sheet 18 constituting the other surface of the outer bag 13 is a sheet that cannot be infiltrated by the volatile drug 15. That is, unlike the aforementioned microporous sheet 17, the volatile drug 15 does not infiltrate.
  • the transparent sheet 18 that does not infiltrate the volatile drug 15 is either a gas permeable film that allows the gas of the volatile drug 15 to permeate at a molecular level or a gas non-permeable film that blocks the gas of the volatile drug 15. Also good.
  • the gas non-permeable film a film that can be selected from the materials used in the inner bag 12 described above may be used.
  • gas permeable film examples include one or more thermoplastic resins such as polyethylene, polypropylene, ethylene-vinyl acetate copolymer resin, ionomer resin, ethylene-acrylic acid copolymer resin, and ethylene- ⁇ -olefin copolymer resin.
  • thermoplastic resins such as polyethylene, polypropylene, ethylene-vinyl acetate copolymer resin, ionomer resin, ethylene-acrylic acid copolymer resin, and ethylene- ⁇ -olefin copolymer resin.
  • multi-layer laminate materials comprising
  • the internal pressure of the inner bag body 12 is increased by the action of an external force (see the white arrow in the figure), and the three sides 16 sealed are sealed.
  • the volatile drug 15 enclosed in the inner bag body 12 flows into the outer bag body 13.
  • the outer bag 13 is composed of a microporous sheet 17 having one side (upper surface in the figure) having a large number of micropores into which the volatile drug 15 can infiltrate, the outer bag 13 flows into the outer bag 13.
  • the volatile chemical 15 infiltrates through the micropores of the microporous sheet 17 and oozes out to the surface of the sheet, and then volatilizes to the outside (see the broken line arrow in the figure).
  • the microporous sheet 17 constituting one surface of the outer bag body 13 is one in which a large number of micropores are physically formed to such an extent that the volatile drug 15 infiltrates and exudes to the sheet surface. Therefore, unlike the conventional gas permeable film, it is not necessary to select a combination with the volatile agent 15 having various chemical properties, and there are various types of volatile agents 15 that can be used. It can be easily volatilized from the bag 13. Thus, since the usable volatile chemical
  • This microporous sheet 17 infiltrates the volatile agent 15 with a large number of micropores and oozes out on the surface of the sheet, so that the volatilization amount of the volatile agent 15 increases even when compared with the gas permeable film,
  • the volatile chemical 15 can be volatilized well from the outer bag 13. Therefore, it is not necessary to configure both surfaces of the outer bag 13 with the microporous sheet 15, and only one surface of the outer bag 13 may be configured with the microporous sheet 15.
  • the other surface of the outer bag 13 may be formed of a sheet that cannot be infiltrated by the volatile drug 15 such as a gas permeable film or a gas non-permeable film.
  • FIG. 5 illustrates a case 21 having a two-part structure in which two case halves 23 and 24 are abutted, (A) is a top view, and (B) is a front view.
  • FIG. 6C is a bottom view
  • FIG. 6 is a sectional view taken along line BB in FIG. 5A
  • FIG. 7 is a bottom view of one case half 23 (hereinafter referred to as the upper case)
  • FIG. 9 is a top view of the other case half 24 (hereinafter referred to as the lower case)
  • FIG. 10 is a cross-sectional view taken along the line DD of FIG. .
  • the case 21 has a two-part structure in which two circular dish-like upper and lower cases 23 and 24 are abutted.
  • the case 21 has the following outer peripheral portions of the upper case 23 shown in FIGS. 7 and 8 and the lower case 24 shown in FIGS. 9 and 10 so that the used medicine volatilization bag 11 can be replaced as follows.
  • the structure is provided.
  • the upper and lower cases 23, 24 can be aligned with a structure in which the pin 25 of the upper case 23 is inserted into the concave hole 26 of the lower case 24, and the claw 27 of the upper case 23 and the claw 28 of the lower case 24 are
  • the upper and lower cases 23 and 24 can be separated by a one-touch type by a hooking and locking structure.
  • the fitting structure is separable by a hooking and locking structure between the claws 27 and 28, but the used medicine volatilization bag 11 can be exchanged by making the hinge structure openable and closable. May be.
  • the upper case 23 is provided with a circular pressing portion 29 that applies an external force to the inner bag body 12 of the drug volatilization bag 11 via the outer bag body 13 at the central portion thereof.
  • the pressing portion 29 is integrally formed in a state where it is cantilevered and supported by the upper case 23 via a flexible connecting portion 30 and can be pushed in by being disposed in the opening 31 of the upper case 23. Yes.
  • a plurality of volatilization holes 32 for releasing the drug gas of the volatile drug 15 are opened.
  • the upper case 23 is provided with four corners 33 (see FIG. 9) of the outer bag body 13 of the drug volatilization bag 11 positioned and placed on the lower case 24 when the upper and lower cases 23 and 24 meet.
  • Four pushing ribs 34 to be pushed inwardly are integrally formed at portions corresponding to the four corners 33 of the outer bag 13.
  • the lower case 24 is integrally provided with four support ribs 35 on which the outer bag 13 of the chemical volatilization bag 11 is placed.
  • four position regulating ribs 36 that integrally position the outer bag body 13 by being in contact with the side portions 19 of the outer bag body 13 are erected integrally.
  • the front end portion of the position restricting rib 36 has a hook shape, and the outer bag body 13 is pressed by the hook-shaped front end portion to prevent the outer bag body 13 from floating, thereby stabilizing the position restriction.
  • a receiving portion 37 that supports the inner bag body 12 of the drug volatilization bag 11 to which an external force is applied by the pressing portion 29 via the outer bag body 13 is integrally provided at the central portion of the lower case 24.
  • the receiving portion 37 has a support surface 38 that is inclined so as to face the pressing portion 29 that has been pushed in, and the medicine volatilization bag 11.
  • the receiving portion 37 has a double structure of the inner circular rib 39 and the outer circular rib 40, and the support surface 38 is at the upper end portion of the inner circular rib 39 and the cross-shaped rib 41 and the outer circular rib 40 located inside thereof. It is configured.
  • an adhesive tape 42 for attaching the drug volatilization container 22 to the inner side of the lid of the trash box is provided at the outer central portion of the lower case 24.
  • the lower case 24 is not provided with a volatilization hole 32. Since the adhesive tape 42 for attaching the chemical volatilization container 22 to the inner side of the lid of the trash box is attached to the lower case 24, the lower case 24 has no volatilization hole 32.
  • the volatile chemical 15 that volatilizes can prevent the adhesive force of the adhesive tape 42 disposed in the vicinity of the lower case 24 from being lowered, and prevent the material of the lid of the trash can from being damaged.
  • FIGS. 11 to 13 exemplify the drug volatilization container 22 in which the drug volatilization bag 11 is assembled to the above-described case 21, FIG. 11 and FIG. 12 are exploded perspective views, and FIG.
  • the rectangular drug volatilization bag 11 is placed on the support rib 35 of the lower case 24 so that the microporous sheet 17 of the outer bag 13 faces the lower case 24 side, and each side of the drug volatilization bag 11 is placed.
  • the chemical volatilization bag 11 is positioned by bringing the portion 19 into contact with the position regulating rib 36 from the side.
  • the upper case 23 is aligned with the lower case 24 on which the medicine volatilization bag 11 is positioned and placed with a structure including the pin 25 of the upper case 23 and the concave hole 26 of the lower case 24, and the claw 27 of the upper case 23
  • the lower case 24 is fitted with a hook and lock structure with the claw 28. In this way, the assembly of the chemical volatilization bag 11 to the case 21 is completed.
  • the four corners 33 of the outer bag 13 of the drug volatilization bag 11 positioned and placed on the lower case 24 are positioned on or near the outer peripheral portions of the upper and lower cases 23 and 24. For this reason (see FIG. 9), there is a possibility that the upper and lower cases 23 and 24 may be bitten between the outer peripheral portions or protrude from the outer peripheral portions. Therefore, the pushing ribs 34 provided on the upper case 23 push the four corners 33 of the outer bag 13 of the chemical volatilization bag 11 into the lower case 24 when the upper and lower cases 23 and 24 meet.
  • the adhesive tape 42 provided on the lower case 24 is used to attach the chemical volatilization container 22 to a member to be attached. It sticks inside the lid 44 of the trash box 43. That is, the chemical volatilization container 22 is attached in an upside down state in which the upper case 23 faces downward and the lower case 24 faces upward. In this attached state, the drug volatilization container 22 is held in a substantially horizontal state, and the drug volatilization bag 11 accommodated in the drug volatilization container 22 is held with the microporous sheet 17 facing upward. On the other hand, before or after attaching the chemical volatilization container 22 to the lid 44 of the trash box 43, the inner bag 12 of the chemical volatilization bag 11 is broken by the following operation.
  • an external force is applied to the inner bag body 12 via the outer bag body 13 of the drug volatilization bag 11 by pushing the pressing portion 29 provided in the upper case 23 of the drug volatilization container 22 into the container.
  • the internal pressure of the inner bag body 12 is increased, and the inner bag body 12 is broken by the increase of the internal pressure. Since the three side portions 16 are sealed with such a strength that the inner bag body 12 can be broken by an increase in internal pressure due to external force, a part or all of the three side portions 16 are opened. Done.
  • the pressing portion 29 provided on the upper case 23 via the connecting portion 30 has the connecting portion 30 having flexibility. It is pushed into the container by the bending of 30 Due to the pressing operation of the pressing portion 29, the drug volatilization bag 11 is sandwiched between the receiving portion 37 of the lower case 24 and the pressing portion 29.
  • the support surface 38 of the receiving portion 37 composed of the inner circular rib 39 and the cross-shaped rib 41 and the outer circular rib 40 is inclined so as to face the pressing portion 29 inclined by the pushing operation through the drug volatilization bag 11. Therefore, since the pressing surface 45 of the pressing part 29 and the support surface 38 of the receiving part 37 are parallel, the entire surface of the pressing part 29 contacts the drug volatilization bag 11.
  • the contact area of the press part 29 and the medicine volatilization bag 11 can be ensured to the maximum, a sufficient external force can be applied by the press part 29, and the inner bag body 12 of the drug volatilization bag 11. Can be surely broken.
  • the inner bag body 12 is broken with a simple structure including the pressing portion 29 of the upper case 23 and the receiving portion 37 of the lower case 24 and provided in the case 21 located outside the drug volatilization bag 11. be able to.
  • the volatile drug 15 enclosed in the inner bag body 12 flows into the outer bag body 13 as shown in FIG. Since the outer bag 13 is composed of a microporous sheet 17 having a large number of micropores into which the volatile drug 15 can infiltrate, the volatile drug that has flowed into the outer bag 13. 15 is volatilized to the outside by infiltrating through the micropores of the microporous sheet 17 and oozing out onto the sheet surface. Volatile medicine 15 volatilized outside the outer bag 13 is released to the outside of the container through a volatilization hole 32 and an opening 31 provided in the upper case 23 of the chemical volatilization container 22. In this way, by filling the inside of the trash box 43 with the volatile chemical 15 volatilized to the outside of the container, the chemical volatilization container 22 functions as the fragrance of the trash box 43.
  • medical agent 15 enclosed with the inner side bag body 12 of the chemical volatilization bag 11 is colored, since the surface which faces the upper case 23 side of the outer side bag body 13 is comprised with the transparent sheet 18, Since the volatile chemical
  • the chemical volatilization container 22 is disposable, the disposal timing of the chemical volatilization container 22 can be recognized quickly and easily. Moreover, when the chemical volatilization container 22 can be refilled, the replacement time of the chemical volatilization bag 11 can be recognized quickly and easily.
  • the chemical volatilization bag 11 is composed of the soft inner bag body 12 and the outer bag body 13, even if the volatile chemical agent 15 is reduced by the volatilization of the volatile chemical agent 15, the volatile chemical agent 15 is reduced.
  • the microporous sheet 17 of the outer bag 13 is in close contact with the volatile chemical 15 by the internal pressure reduction accompanying the above. As described above, since the air layer is not formed between the microporous sheet 17 and the volatile agent 15 and the microporous sheet 17 and the volatile agent 15 are always in contact with each other, the volatile agent 15 is eliminated.
  • medical agent 15 infiltrates the microporous sheet
  • the chemical volatilization bag 11 is held in a horizontal state inside the lid 44 of the waste bin 43 as a fragrance of the waste bin 43, that is, in a so-called horizontal state.
  • the drug volatilization container 22 in which the drug volatilization bag 11 is placed in the case 21 in the horizontal state, as described above, one surface of the outer bag body 13 constituted by the microporous sheet 17 is set on the upper side.
  • the above embodiment demonstrated the usage pattern of the chemical volatilization container 22 which arrange
  • this invention is not limited to this,
  • positions in a case in a vertical state may be sufficient. In this case, even if the volatile chemical 15 infiltrated by a large number of micropores in the microporous sheet 17 and exuded on the surface of the sheet becomes a liquid droplet, it falls to the outside of the case by receiving the liquid droplet in the case. This can be suppressed.

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Disinfection, Sterilisation Or Deodorisation Of Air (AREA)
  • Packaging Of Annular Or Rod-Shaped Articles, Wearing Apparel, Cassettes, Or The Like (AREA)

Abstract

L'objet de la présente invention consiste à améliorer le degré de liberté de sélection lors de l'utilisation de produits chimiques volatils tels que des assainisseurs d'air ou des désodorisants. La solution selon l'invention concerne un dispositif pourvu d'un corps (12) de sachet côté interne souple formé d'un film (14) imperméable aux gaz et comportant un produit chimique (15) isolé en son sein, et un corps (13) de sachet côté externe souple destiné à recevoir le corps (12) de sachet côté interne. Le corps (12) de sachet côté interne est conçu de sorte à être déchirable du fait d'une augmentation de la pression interne au moyen d'une force externe, le corps (13) côté externe présente une surface et une autre surface faisant face à celle-ci, au moins l'une des surfaces étant composée d'une feuille (17) micro-poreuse comportant une pluralité de micro-pores à travers lesquels le produit chimique (15) volatil peut s'infiltrer.
PCT/JP2014/084474 2013-12-26 2014-12-26 Sachet de volatilisation chimique et contenant de volatilisation chimique le contenant WO2015099108A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2013-269805 2013-12-26
JP2013269805A JP6647768B2 (ja) 2013-12-26 2013-12-26 薬剤揮散袋及びこれを収納する薬剤揮散容器

Publications (1)

Publication Number Publication Date
WO2015099108A1 true WO2015099108A1 (fr) 2015-07-02

Family

ID=53478947

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2014/084474 WO2015099108A1 (fr) 2013-12-26 2014-12-26 Sachet de volatilisation chimique et contenant de volatilisation chimique le contenant

Country Status (3)

Country Link
JP (1) JP6647768B2 (fr)
TW (1) TWI663994B (fr)
WO (1) WO2015099108A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6453128B2 (ja) * 2015-03-25 2019-01-16 小林製薬株式会社 薬剤揮散器
JP6462162B2 (ja) * 2016-02-10 2019-01-30 佐伯　午郎 除菌装置
JP6805689B2 (ja) * 2016-09-30 2020-12-23 大日本印刷株式会社 香り放出機能付き箱体
JP2021000996A (ja) * 2019-06-19 2021-01-07 小林製薬株式会社 薬剤揮散器
JP2021000997A (ja) * 2019-06-19 2021-01-07 小林製薬株式会社 薬剤揮散器
CN112386734A (zh) * 2019-08-15 2021-02-23 睿泽企业股份有限公司 挥发性液体的容纳装置
JP7391731B2 (ja) 2020-03-13 2023-12-05 株式会社カーメイト 徐放具

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5377984U (fr) * 1976-12-01 1978-06-29
JPS5695240U (fr) * 1979-12-21 1981-07-28
JPS58153836U (ja) * 1982-04-08 1983-10-14 昭和ラミネ−ト印刷株式会社 香袋
JPS62172929A (ja) * 1986-01-24 1987-07-29 松下電器産業株式会社 電気掃除機
JPH08131527A (ja) * 1994-11-04 1996-05-28 Dainippon Printing Co Ltd 芳香剤容器
JP2007161342A (ja) * 2005-12-16 2007-06-28 Aikurappu:Kk 耐水シート、安全容器及びそれを用いた芳香容器並びに芳香容器収納具
JP2012205794A (ja) * 2011-03-30 2012-10-25 Dainippon Printing Co Ltd 薬剤蒸散容器
JP2013078348A (ja) * 2011-09-30 2013-05-02 Kobayashi Pharmaceutical Co Ltd 薬液揮散容器、及びこれを支持する薬液揮散装置

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5377984A (en) * 1976-12-22 1978-07-10 Toshiba Corp Sequence controller
GB2058670B (en) * 1979-09-10 1983-03-30 Embassy Litho Plates Pty Producing registration punchings in preparing printing plates

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5377984U (fr) * 1976-12-01 1978-06-29
JPS5695240U (fr) * 1979-12-21 1981-07-28
JPS58153836U (ja) * 1982-04-08 1983-10-14 昭和ラミネ−ト印刷株式会社 香袋
JPS62172929A (ja) * 1986-01-24 1987-07-29 松下電器産業株式会社 電気掃除機
JPH08131527A (ja) * 1994-11-04 1996-05-28 Dainippon Printing Co Ltd 芳香剤容器
JP2007161342A (ja) * 2005-12-16 2007-06-28 Aikurappu:Kk 耐水シート、安全容器及びそれを用いた芳香容器並びに芳香容器収納具
JP2012205794A (ja) * 2011-03-30 2012-10-25 Dainippon Printing Co Ltd 薬剤蒸散容器
JP2013078348A (ja) * 2011-09-30 2013-05-02 Kobayashi Pharmaceutical Co Ltd 薬液揮散容器、及びこれを支持する薬液揮散装置

Also Published As

Publication number Publication date
JP6647768B2 (ja) 2020-02-14
TWI663994B (zh) 2019-07-01
JP2015123992A (ja) 2015-07-06
TW201529108A (zh) 2015-08-01

Similar Documents

Publication Publication Date Title
WO2015099108A1 (fr) Sachet de volatilisation chimique et contenant de volatilisation chimique le contenant
US9675723B2 (en) Device and method for delivering volatile substances
JP2010528941A (ja) 吸収性材料裏地を有する輸送用容器
CN103562088A (zh) 用于医疗容器的包装
TWM495854U (zh) 易破口式揮發物質承載裝置
JP5621179B2 (ja) 自立性袋体
JP2012051633A (ja) 分離可能な蓋材及びそれを用いた容器
AU2007358835A1 (en) Container for evaporating volatile substances and method of manufacturing said container
JP2007209705A (ja) 複室容器
JP6453128B2 (ja) 薬剤揮散器
JP3218475U (ja) 乾燥食品包装袋の包装保存容器
JP5425923B2 (ja) 二重容器およびその製造方法
JP6190624B2 (ja) 揮散体
JP7153428B2 (ja) 蓋材および包装体
CN104159729B (zh) 包装材料、由其生产的包装，以及构造包装的方法
JP5467465B2 (ja) 芳香剤容器
JP2000007066A (ja) 詰め替え用ポンプ付き容器
JP2008081179A (ja) 包装袋
JPS601730Y2 (ja) 芳香剤包装体
JP6536132B2 (ja) プレススルーパック包装体
JP3171472U (ja) 除菌消臭剤パック
JP5355925B2 (ja) 粘着ラベル付き包装体
JP2013112367A (ja) 包装袋
WO2022196526A1 (fr) Récipient rempli de liquide
JP5974308B2 (ja) 包装体

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14875393

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 14875393

Country of ref document: EP

Kind code of ref document: A1